Join Growin Stock Community!
Back to PFE.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

contract-liabilities-chart

PFE Current Contract Liabilities

Current Contract Liabilities

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, Pfizer's current contract liabilities have decreased to 0 USD, marking a significant reduction from the previous quarter's value of 924M USD. This latest data point reflects a complete drawdown of current contract liabilities by the end of 2025. Over the period from Q1'23 to Q4'25, the chart shows notable volatility, with liabilities peaking at 2.7B USD in Q4'23 before entering a sustained decline throughout 2024 and 2025. After reaching 2.53B USD in Q2'24, there is a consistent downward trend, culminating in a full reduction to zero by Q4'25, indicating either fulfillment or cancellation of outstanding contractual obligations.